Advertisement
Advertisement
CUPR
C
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
0.28
USDSponsored
+0.02
+6.02%
May 08, 15:56 UTC -4
Closed
After-Market
0.28
0.00
+0.75%
CUPR Earnings Reports
Positive Surprise Ratio
No Data Available for CUPR
0%
Next Report
Next Week
Date of Next Report
May 12, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares earnings per share and revenue
On --, CUPR reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Werewolf Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.28
Surprise
+3.68%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
FAQ
What were Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Cuprina Holdings (Cayman) Limited Class A Ordinary Shares expected to report next?
The next earning report is scheduled for May 12, 2026.
What are the forecasts for Cuprina Holdings (Cayman) Limited Class A Ordinary Shares's next earnings report?
Based on --
analysts, Cuprina Holdings (Cayman) Limited Class A Ordinary Shares is expected to report EPS of -- and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement